Complexing the Marine Sesquiterpene Euplotin C by Means of Cyclodextrin-Based Nanosponges: A Preliminary Investigation
- PMID: 36355005
- PMCID: PMC9692710
- DOI: 10.3390/md20110682
Complexing the Marine Sesquiterpene Euplotin C by Means of Cyclodextrin-Based Nanosponges: A Preliminary Investigation
Abstract
Euplotin C is a sesquiterpene of marine origin endowed with significant anti-microbial and anti-tumor properties. Despite the promising functional profile, its progress as a novel drug candidate has failed so far, due to its scarce solubility and poor stability in aqueous media, such as biological fluids. Therefore, overcoming these limits is an intriguing challenge for the scientific community. In this work, we synthesized β-cyclodextrin-based nanosponges and investigated their use as colloidal carriers for stably complex euplotin C. Results obtained proved the ability of the carrier to include the natural compound, showing remarkable values of both loading efficiency and capacity. Moreover, it also allowed us to preserve the chemical structure of the loaded compound, which was recovered unaltered once extracted from the complex. Therefore, the use of β-cyclodextrin-based nanosponges represents a viable option to vehiculate euplotin C, thus opening up its possible use as pharmacologically active compound.
Keywords: ATR-FTIR analysis; ESI-MS analysis; LC-DAD-ESI-MS analysis; NMR analysis; SPE; euplotin C; β-cyclodextrin; β-cyclodextrin-based nanosponges.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.Curr Pharm Des. 2016;22(46):6988-6997. doi: 10.2174/1381612822666161216113207. Curr Pharm Des. 2016. PMID: 27981908
-
Engineered Porous Beta-Cyclodextrin-Loaded Raloxifene Framework with Potential Anticancer Activity: Physicochemical Characterization, Drug Release, and Cytotoxicity Studies.Int J Nanomedicine. 2024 Nov 9;19:11561-11576. doi: 10.2147/IJN.S469570. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39539969 Free PMC article.
-
Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.Colloids Surf B Biointerfaces. 2015 Dec 1;136:105-10. doi: 10.1016/j.colsurfb.2015.09.002. Epub 2015 Sep 3. Colloids Surf B Biointerfaces. 2015. PMID: 26364091
-
Cyclodextrin Nanosponges: A Revolutionary Drug Delivery Strategy.Pharm Nanotechnol. 2024;12(4):300-313. doi: 10.2174/0122117385273293230927081513. Pharm Nanotechnol. 2024. PMID: 37807414 Review.
-
Cyclodextrin based nanosponges for pharmaceutical use: a review.Acta Pharm. 2013 Sep;63(3):335-58. doi: 10.2478/acph-2013-0021. Acta Pharm. 2013. PMID: 24152895 Review.
Cited by
-
Cyclodextrin nanoparticles in targeted cancer theranostics.Front Pharmacol. 2023 Aug 3;14:1218867. doi: 10.3389/fphar.2023.1218867. eCollection 2023. Front Pharmacol. 2023. PMID: 37601050 Free PMC article. Review.
References
-
- Trielli F., Cervia D., Di Giuseppe G., Ristori C., Kruppel T., Burlando B., Guella G., Viarengo A., Bagnoli P., Umberta M., et al. Action mechanisms of the secondary metabolite euplotin C: Signaling and functional role in Euplotes. J. Eukaryot. Microbiol. 2008;55:365–373. doi: 10.1111/j.1550-7408.2008.00335.x. - DOI - PubMed
-
- Cervia D., Martini D., Garcia-Gil M., Di Giuseppe G., Guella G., Dini F., Bagnoli P. Cytotoxic effects and apoptotic signalling mechanisms of the sesquiterpenoid euplotin C, a secondary metabolite of the marine ciliate Euplotes crassus, in tumour cells. Apoptosis. 2006;11:829–843. doi: 10.1007/s10495-006-5700-3. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous